Catalyst Funds Management’s Syndax Pharmaceuticals SNDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-2,800
Closed -$57.5K 1584
2024
Q2
$57.5K Buy
+2,800
New +$57.5K 0.02% 391